Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Akela Pharma, Inc.

Home Clinical Trial Sponsors and OrganizationsAkela Pharma, Inc.

Akela Pharma, Inc.

ACTIVE

11011 Torreyana Rd # 100, 德克萨斯州奥斯汀县, Texas, United Statesakelapharma.comPrivate1–10 employeesEstablished: 1996-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

10

7 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1996

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

5

50.0%

Phase 1

1

10.0%

Trial Status Distribution

Active, not recruiting

5

50.0%

Not yet recruiting

2

20.0%

Unknown

1

10.0%

Clinical Trials

Trials sponsored by this organization (10)

A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial to Evaluate Efficacy and Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy. - FINDE: Fentanyl In Neoplastic Disease Efficacy

Active, not recruiting

Feb 2009180 participants

Safety of Fentanyl TAIFUN Treatment

Dec 2008500 participants

A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial to Evaluate Efficacy and Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy. - FINDE: Fentanyl In Neoplastic Disease Efficacy

Active, not recruiting

Nov 2008180 participants

A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial to Evaluate Efficacy and Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy. - FINDE: Fentanyl In Neoplastic Disease Efficacy

Active, not recruiting

Nov 2008180 participants

A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial to Evaluate Efficacy and Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy. - FINDE: Fentanyl In Neoplastic Disease Efficacy

Active, not recruiting

Jun 2008180 participants

A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate the Safety of Fentanyl TAIFUN® Treatment after Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy. - FINDS: Fentanyl In Neoplastic Disease Safety

Active, not recruiting

May 2008500 participants

A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapy

Not yet recruiting

180 participants

A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapy

180 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials10
Approvals
News

Back to Organizations